US Patent 9168226 Injectable particle
All edits
Edits on 21 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+352 characters)
Article
Patent abstract
The present invention provides an injectable particle comprising dasatinib acetate and a hyaluronic acid. The hyaluronic acid may be acetylated or sulfated. The particle is for the use of cancer therapy. The injectable particle may further comprises an acid, wherein the acid is dispersed evenly in the matrix of the injectable particle.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09168226 Injectable particle US Patent 9168226 Injectable particle
Infobox
Patent Number
0916822600
Patent Number
916822600
Edits on 1 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
091682260
Date of Patent
October 27, 2015
0Patent Application Number
148215850
Date Filed
August 7, 2015
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
091682260
Date of Patent
October 27, 2015
0Patent Application Number
148215850
Date Filed
August 7, 2015
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 09168226 Injectable particle
Infobox
Is a
Patent jurisdiction
Patent number
09168226
Date of patent
October 27, 2015
Patent application number
14821585
Date Filed
August 7, 2015
Patent primary examiner
Find more entities like US Patent 9168226 Injectable particle
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
